Unmasking Pulmonary Amyloidosis: A Mimic of Lung Cancer
"How a Rare Condition Masqueraded as Lung Malignancy in an Indigenous Australian Woman with Sjogren's Syndrome"
Pulmonary nodules and cysts can arise from many different conditions. Sjogren's syndrome, primarily known for causing dry eyes and mouth, can also affect the lungs. Lung problems linked to Sjogren's typically include interstitial lung disease (ILD) and issues with the trachea and bronchi. In very rare instances, amyloidosis—specifically in the form of nodules and cysts—occurs secondary to Sjogren's syndrome.
This article delves into the case of a 52-year-old Australian Indigenous woman with Sjogren's syndrome, whose initial diagnosis pointed towards metastatic lung cancer due to a concerning nodule found on a PET scan. Further investigation revealed a surprising alternative.
Through this case, we aim to emphasize the diagnostic challenges and the importance of considering less common conditions, even when initial findings suggest something more typical.
Rare but Cancer-Mimicking
Pulmonary amyloidosis secondary to Sjögren's syndrome is rare, and the 2010 case report described a 41-year-old woman with diffuse septal pulmonary AL (λ) amyloidosis without systemic amyloidosis. In another reported case, a 75-year-old woman with primary Sjögren's syndrome developed lung nodules identified as AL (κ) pulmonary amyloidomas. CT showed relatively well-circumscribed calcified and ground-glass nodules measuring up to 2.7 cm, findings that can overlap with malignancy and other lung disorders.
Diagnosis Requires Tissue
For Sjögren's syndrome patients with suspected nodular pulmonary amyloidosis, tissue biopsy combined with exclusion of systemic amyloidosis is reported as the only method for distinguishing Sjögren's-related disease, amyloidosis, or concurrent disease. Published cases describe abnormal imaging that may include multiple lung cysts and calcified nodules. Consensus guidance also notes that pulmonary involvement in Sjögren's syndrome is underdiagnosed and affects approximately 16% of patients, while CT pulmonary angiography for suspected embolism should be guided by individual clinical suspicion rather than performed routinely.
An Evolving Recognition
The medical understanding of pulmonary amyloidosis has developed through case reports, imaging observations, and efforts to distinguish localized disease from systemic involvement. Its relationship with Sjögren's syndrome appears uncommon and clinically variable. Because the available evidence is limited, the historical record should be interpreted as an evolving body of observations rather than a complete account of the disease.
The Case: Unveiling the True Diagnosis
A 52-year-old Australian Indigenous woman, already diagnosed with Sjogren's syndrome a decade prior, presented with a persistent dry cough lasting six months. Aside from this, she reported no other respiratory symptoms or general signs of illness like fever or weight loss. Her history included a teenage smoking habit, and she only took NSAIDs for occasional back pain. Physical examination revealed an enlarged thyroid gland, but was otherwise unremarkable.
- Bronchoscopy: Initially, a bronchoscopy (a procedure to visualize the airways) found no abnormalities.
- Biopsy Complication: A CT-guided biopsy of the concerning nodule was attempted, but it led to a pneumothorax (collapsed lung) and yielded inconclusive results.
- Surgical Revelation: Ultimately, a surgical wedge resection (removal of a small piece of the lung) was performed. Microscopic examination revealed amorphous material that, when stained with Congo red and viewed under polarized light, displayed apple-green birefringence. This distinctive finding confirmed the diagnosis of pulmonary AL amyloidosis.
Evidence Remains Case-Based
Recent literature on pulmonary amyloidosis in Sjögren's syndrome continues to rely substantially on case reports and focused reviews. These reports examine different pulmonary patterns, including septal disease, cysts, and calcified nodules. The evidence therefore helps define recognizable presentations but does not yet establish a broad, uniform clinical profile.
Imaging Alone Can Mislead
A central diagnostic limitation is that pulmonary amyloid nodules can resemble lung cancer or other pulmonary conditions on imaging. Calcified and ground-glass nodules may enter a differential diagnosis that includes atypical adenomatous hyperplasia, lymphoma, and amyloid nodules. This overlap means that radiographic appearance alone may not reliably identify the underlying disease.
Localized Versus Systemic Disease
Pulmonary amyloidosis may appear as localized lung disease or as part of broader systemic amyloidosis, and distinguishing these possibilities is clinically important. Reported Sjögren's-associated cases include pulmonary AL (λ) and AL (κ) amyloid patterns. The differing presentations reinforce that pulmonary findings should be interpreted alongside tissue analysis and assessment for systemic involvement.
Key Takeaways: Amyloidosis and Diagnostic Vigilance
This case underscores the importance of considering rare conditions like pulmonary amyloidosis, especially in patients with autoimmune disorders such as Sjogren's syndrome. While lung nodules and cysts often raise concerns for cancer, this case demonstrates that other possibilities should be thoroughly investigated.
A Diagnostic Mimic
Pulmonary amyloidosis associated with Sjögren's syndrome illustrates how a rare autoimmune-related lung complication can imitate more familiar diagnoses. The combination of nonspecific respiratory symptoms and potentially suspicious nodules creates a risk of diagnostic uncertainty. A careful synthesis of clinical context, imaging, biopsy findings, and systemic evaluation is therefore essential.
Toward Targeted Treatment
Future Sjögren's syndrome research is expected to pursue new targeted therapies and treatment strategies. Pulmonary amyloidosis remains a rare complication of primary Sjögren's syndrome, which makes focused evidence especially important for affected patients. Progress will depend on translating broader advances in Sjögren's treatment into approaches relevant to pulmonary involvement.
Recognition and Coordination
Rare pulmonary disorders create broader challenges because their findings may overlap with common and serious diseases such as lung cancer. Diagnosis may require coordination among pulmonary, rheumatology, radiology, pathology, and other clinical teams. Limited disease-specific evidence can also make consistent evaluation and management more difficult.
Living With Uncertainty
For patients, an abnormal lung scan can bring significant uncertainty when the findings resemble cancer but may reflect a rare autoimmune-related condition. The need for biopsy and systemic assessment can lengthen the diagnostic process. Clear communication and coordinated follow-up are important parts of care while the diagnosis is being established.
Pulmonary amyloidosis secondary to Sjogren's syndrome is rare and can be difficult to diagnose. The case highlights the diagnostic challenges and the importance of surgical lung biopsy in confirming the diagnosis and excluding other conditions.
This case adds to the growing body of knowledge on the pulmonary manifestations of both amyloidosis and Sjogren's syndrome, reminding clinicians to maintain a broad differential diagnosis and utilize appropriate diagnostic tools to ensure accurate and timely diagnosis, especially in complex presentations.